Article
Sensitive genotyping of mutations in the EGFR gene from NSCLC patients using PCR-GoldMag lateral flow device.
Scientific reports - 21 Aug 2017
Li Xian-Ying, Zhang Chao, Zhang Qin-Lu, Zhu Juan-Li, Liu Qian, Chen Ming-Wei, Yang Xue-Min, Hui Wen-Li, Cui Ya-Li
Abstract excerpt
Epidermal growth factor receptor (EGFR) mutations predict better outcomes with EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer (NSCLC). Most common activating mutations include in-frame deletion in exon 19 and L858R substitution in exon 21, which account for >90% of all EGFR mutations in NSCLC. In this study, a PCR-GoldMag lateral flow assay (PCR-GoldMag LFA) was developed for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
